Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2005
09/21/2005EP1220857B1 Gonadotropin releasing hormone receptor antagonists and their related methods of use
09/21/2005EP1198222B1 Skin care composition
09/21/2005EP1189522B1 Use of nanoscale sterols and sterol esters
09/21/2005EP1163217B1 New salt of (2r,3r,4r)-3,4-dihydroxy-2-hydroxymethylpyrrolidine
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005EP1098630B1 Composition for enhancing epidermal lipid production
09/21/2005EP1096934B1 Oxazolidinones to treat eye infections
09/21/2005EP1091731B1 Anti-inflammatory pharmaceutical formulations
09/21/2005EP1087791B1 Inhibition of xenoreactive antibodies
09/21/2005EP1061805B1 Regulation of endogenous gene expression in cells using zinc finger proteins
09/21/2005EP1042325B1 Nitrogen-containing heterocyclic compounds, their production and use
09/21/2005EP1028756B1 Water soluble paclitaxel conjugates combined with irradiation for the treatment of cancer
09/21/2005EP1019533B1 Silanol enzyme inhibitors
09/21/2005EP1002065B1 Nanocrystalline formulations of human immunodeficiency virus (hiv) protease inhibitors using cellulosic surface stabilizers and methods of making such formulations
09/21/2005EP0994710B2 Pharmaceutical compositions for oral administration, comprising a benzhydrylpiperazine and a cyclodextrin
09/21/2005EP0959881B1 Synthetic methods for the preparation of indolylquinones and mono- and bis-indolylquinones prepared therefrom
09/21/2005EP0925065B1 Water miscible erythromycin compositions
09/21/2005EP0793721B1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof
09/21/2005EP0712303B1 Skin patches comprising testosterone and optionally estrogen
09/21/2005CN1671863A Central airway administration for systemic delivery of therapeutics
09/21/2005CN1671845A Immunogenic sequences
09/21/2005CN1671831A 消毒组合物 Disinfecting composition
09/21/2005CN1671745A Polysaccharide of echinacea angustifolia
09/21/2005CN1671744A Low molecular weight oversulfated polysaccharide
09/21/2005CN1671734A CFTR modifier genes and expressed polypeptides useful in treating cystic fibrosis and methods and products for detecting and/or identifying same
09/21/2005CN1671730A Oligonucleotide-containing pharmacological compositions and their use
09/21/2005CN1671729A Control sequences of the human Corin gene
09/21/2005CN1671728A Novel adenosine analogues and their use as pharmaceutical agents
09/21/2005CN1671727A Anti-viral 7-deaza D-nucleosides and uses thereof
09/21/2005CN1671726A 3-descladinosyl-6-O-carbamoyl and 6-O-carbonoyl macrolide antibacterial agents
09/21/2005CN1671716A Method of treating ischemia reperfusion injury using adenosine receptor antagonists
09/21/2005CN1671715A Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
09/21/2005CN1671714A Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
09/21/2005CN1671713A Novel derivative of flavone c-glycoside and composition containing the same
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671710A Pyrazolo[1, 5a]pyrimidine compounds as antiviral agents
09/21/2005CN1671708A Novel derivatives of cycloalcanodiones, method for the production thereof and their pharmacological applications
09/21/2005CN1671701A Novel aryllimidazole derivatives, preparation and therapeutic used thereof
09/21/2005CN1671700A Substituted alkylamine derivatives and methods of use
09/21/2005CN1671697A Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
09/21/2005CN1671696A 激酶抑制剂 Kinase inhibitors
09/21/2005CN1671695A Pyrrolidinedione substituted piperidine-phthalazones as PDE4 inhibitors
09/21/2005CN1671694A Bisindolyl-maleimid derivatives as kinase inhibitors
09/21/2005CN1671690A Antimicrobial aza-bicyclic derivates, their compositions and uses
09/21/2005CN1671684A Novel benzodioxoles
09/21/2005CN1671680A Compound for treatment of anxiety and methods of preparation and use thereof
09/21/2005CN1671671A 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) im
09/21/2005CN1671668A 4-(substituted aryl)-5-hydroxyisoquinolinone derivative
09/21/2005CN1671667A Quinoline derivatives and their use as mycobacterial inhibitors
09/21/2005CN1671666A Vegfr-2 and vegfr-3 inhibitory anthranylamidopyridines
09/21/2005CN1671663A Pleuromutilin
09/21/2005CN1671661A Aromatic sulfones and their medical use
09/21/2005CN1671660A 3-z-[1-(4-(n-((4-methyl-piperazin-1-yl)-methylcarbonyl)-n-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate and the use thereof as a pharmaceutical composi
09/21/2005CN1671659A Novel substituted indoles
09/21/2005CN1671650A Crystalline beta2 adrenergic receptor agonist
09/21/2005CN1671649A Process for preparing nateglinide and intermediates thereof
09/21/2005CN1671647A Optically active 1-(fluoro-, trifluoromethyl-or trifluoromethoxy-substituted phenyl) alkylamine n-monoalkyl derivatives and process for producing same
09/21/2005CN1671644A Compounds that abrogate DNA-damage-induced cell cycle G2 checkpoint and/or augment the anti-cancer activity of DNA-damaging treatments
09/21/2005CN1671643A Bipolar trans carotenoid salts and their uses
09/21/2005CN1671639A Novel biphenyl and biphenyl-like cannabinoids
09/21/2005CN1671435A Medicament dispenser
09/21/2005CN1671424A Decoy composition for treating and preventing inflammatory disease
09/21/2005CN1671421A Inclusion complexes of rosiglitazone
09/21/2005CN1671419A A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds
09/21/2005CN1671414A CpG formulations and related methods
09/21/2005CN1671407A Compositions and methods for treating diabetes
09/21/2005CN1671406A Echinacea angustifolia extracts
09/21/2005CN1671401A Poly(potassium and sodium styrene sulfonate), its manufacture and its uses
09/21/2005CN1671400A Compositions of hyaluronic acid and methods of use
09/21/2005CN1671399A Myocardial perfusion imaging using A2A receptor agonists
09/21/2005CN1671398A Compositions and methods for treating epithelia and retinal tissue diseases
09/21/2005CN1671397A Use of alkyl phosphocholines in combination with antitumor medicaments
09/21/2005CN1671396A Medicinal composition for periodontal pocket administration containing bisphosphonic acid derivative or its salt as the active ingredient
09/21/2005CN1671395A Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol
09/21/2005CN1671394A Composition containing an androgenous 11beta-halogen steroid and a progestational hormone, and male contraceptive based on said composition
09/21/2005CN1671393A Targeted oxidative therapeutic formulation
09/21/2005CN1671392A Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
09/21/2005CN1671391A Novel methods and compositions for alleviating pain
09/21/2005CN1671390A Adenosine A2A receptor antagonists for treating restless legs syndrome or related disorders
09/21/2005CN1671389A 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer
09/21/2005CN1671388A Sustained-release tablet composition comprising a dopamine receptor agonist
09/21/2005CN1671387A Aryl substituted hydantoin compounds and their use as sodium channel blockers
09/21/2005CN1671386A Substituted anilinic piperidines as MCH selective antagonists
09/21/2005CN1671385A Parenteral formulations containing a rapamycin hydroxyester
09/21/2005CN1671384A Methods of treating microbial infections in humans and animals
09/21/2005CN1671383A Sustained-release tablet comprising reboxetine
09/21/2005CN1671382A Sustained-release tablet composition of pramipexole
09/21/2005CN1671381A Pramipexole once-daily dosage form
09/21/2005CN1671380A Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors
09/21/2005CN1671379A Hydrazonopyrazole derivatives and their use as therapeutics
09/21/2005CN1671378A Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
09/21/2005CN1671377A 1H-1, 2, 4-triazole-3-carboxamide derivatives as cannabinoid-CB receptor ligands
09/21/2005CN1671376A Composition comprising a cholesterol absorption inhibitor, an HMG-CoA reductase inhibitor and a stabilizing agent
09/21/2005CN1671375A Improved transdermal delivery system for the administration of rotigotine
09/21/2005CN1671373A Compounds useful for the inhibition of ALDH
09/21/2005CN1671372A Food improving blood flow
09/21/2005CN1671371A Combination of an aromatase inhibitor with a bisphosphonate
09/21/2005CN1671370A Composition for solubilization of paclitaxel and preparation method thereof
09/21/2005CN1671369A Topical formulations containing ketoprofen stabilised with sulisobenzone
1 ... 4536 4537 4538 4539 4540 4541 4542 4543 4544 4545 4546 4547 4548 4549 4550 4551 4552 4553 4554 4555 4556 ... 7860